Immunosensor for electrodetection of the C-reactive protein in serum
- 124 Downloads
Epidemiological studies have demonstrated an association between the risk of cardiovascular events and increasing C-reactive protein (CRP) concentration. This paper reports the development of an immunosensor for the assessment of the cardiovascular process using anti-C-reactive protein antibody immobilized onto a gold-printed screen electrode. Positive and negative human sera were successfully evaluated using electrochemical impedance spectroscopy (EIS), differential pulse voltammetry (DPV), and atomic force microscopy (AFM). EIS results show that, after the incubation with positive serum for myocardial infarction, the resistance increased about two times in relation to the negative serum. A linear range from 6.25 to 50 μg mL−1 and detection limit of 0.78 μg mL−1 using DPV were obtained. The immunosensor developed for the CRP detection using gold electrode revealed efficacy and a potential use for the diagnosis and monitoring of the progression of cardiovascular diseases.
KeywordsC-reactive protein Immunosensor Cardiovascular disease Gold electrode
We would like to thank teacher Abílio Borghi for the review of the English manuscript.
The authors are grateful for the financial support from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG).
Compliance with ethical standards
The research project was approved by the Ethics Committee of UFU (number 721.990).
- 5.Montgomery JE, Brown JR (2013) Metabolic biomarkers for predicting cardiovascular disease. Vasc Health Risk Manag 9:37–45Google Scholar
- 12.Chan D, Ng LL (2010) Biomarkers in acute myocardial infarction. BMC Med 8(34):1–11Google Scholar
- 18.Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJ, Ley SV, Aquilina JA, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440:1217–1221CrossRefGoogle Scholar
- 21.Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E (2007) Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115(12):1528–1536CrossRefGoogle Scholar
- 22.Schulz S, Lüdike H, Lierath M, Schlitt A, Werdan K, Hofmann B, Gläser C, Schaller HG, Reichert S (2016) C-reactive protein levels and genetic variants of CRP as prognostic markers for combined cardiovascular endpoint (cardiovascular death, death from stroke, myocardial infarction, and stroke/TIA). Cytokine 88:71–76CrossRefGoogle Scholar
- 28.Sadana A, Sadana N Medical applications of biosensors - Chapter 8. In: Handbook of biosensors and biosensor kinetics, 1st edn. E-Publishing: Elsevier, pp 197–222Google Scholar
- 32.Ashwell GJ, Williams AT, Barnes SA, Chappell SL, Phillips LJ, Robinson BJ, Urasinska-Wojcik B, Wierzchowiec P, Gentle IR, Wood BJ (2011) Self-assembly of amino-thiols via gold-nitrogen links and consequence for in situ elongation of molecular wires on surface-modified electrodes. J Phys Chem C 115:4200–4208CrossRefGoogle Scholar
- 41.Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The proteomics protocols handbook. Humana Press, New York CityGoogle Scholar